"Disease-free world,
We will make it a reality."

CELROS BIOTECH is focused to develop the therapeutic antibodies against novel secreted
inflammatory protein targeting fibrosis diseases including kidney fibrosis, liver fibrosis, and lung fibrosis.

CELROS BIOTECH is also developing therapeutic agents to inhibit NADPH oxidase (Nox)
isozymes that generate reactive oxygen species (ROS) involving in neurodegenerative
diseases (Parkinson’s Disease and Alzheimer's Disease).
We are focusing on developing eye-drop medication for age-related macular
degeneration (AMD) and treatment for glioblastoma multiforme (GBM).

With the development of bioscience, many therapeutics are being
developed for the treatment of various diseases.
We will be dedicated to basic research and development of novel therapeutic
antibodieas and agents curing the inflammatory and fibrosis diseases.

Thank you.